Physician profile
William R Doran
NPI 1790070035
$13,463.15
in general payments reported to CMS, 2019-2025
14 companies · $967 in 2025
The $967 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,377 · 2020: $2,302 · 2021: $2,559 · 2022: $714 · 2023: $36.97 · 2024: $1,508 · 2025: $967.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,990 · Food and Beverage: $521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,990.04 |
| Food and Beverage | $521.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,818.40 | 2019-2025 | Pro, Mako, Pangea |
| Supreme Orthopedic Systems, LLC | $5,000.33 | 2019-2022 | |
| Arthrex, INC. | $2,325.16 | 2019 | |
| Biocomposites INC | $96.45 | 2021 | |
| Depuy Synthes Sales INC. | $39.79 | 2022-2025 | Monovisc |
| Heron Therapeutics, INC. | $36.97 | 2023 | Zynrelef |
| Kci USA, INC. | $30.96 | 2020 | |
| Abbott Laboratories | $23.70 | 2022 | |
| Bioventus LLC | $20.65 | 2025 | Exogen Ultrasound Bone Healing System |
| Dynasplint Systems INC. | $16.58 | 2025 | Dynasplint |
| Sanara Medtech INC. | $15.96 | 2024 | Biasurge |
| Djo, LLC | $14.30 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $12.50 | 2019 | |
| Smith+Nephew, INC. | $11.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Doran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.